Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Texas A&M, University of Houston and Baylor Partner to Research Environmental Health

Published: Thursday, April 24, 2014
Last Updated: Thursday, April 24, 2014
Bookmark and Share
New center will bring advances in research to community, for direct impact.

Globally, more than one quarter of all deaths and disease can be attributed to the environment. The University of Houston has joined with partners across the Texas A&M System and the Texas Medical Center to create the Center for Translational Environmental Health Research (CTEHR), a cross-institutional initiative to promote integrated environmental health research and translate research advances into practices that can improve human health.

The center, named by the National Institutes of Health as the newest national Center of Excellence in Environmental Health Science, will be led by Cheryl Lyn Walker of the Texas A&M Health Science Center Institute of Biosciences and Technology and College of Veterinary Medicine & Biomedical Sciences.

“The Texas Medical Center is the most important health-related district in the world, but until now, no entity has existed to lead the world-class research performed here in the area of human environmental health,” said Dr. Brett P. Giroir, executive vice president and CEO of Texas A&M Health Science Center. “Through their combined efforts, CTEHR will harness the unparalleled scientific capabilities of this resource-rich location to promote new discoveries, and then translate these discoveries into preventions and treatments that could save millions of lives worldwide.”

In addition to UH, the initiative includes researchers from institutions across the Texas A&M System and Baylor College of Medicine.

Dr. Jan-Ake Gustafsson, director of the Center for Nuclear Receptors and Cell Signaling at UH and a member of CTEHR, said he would bring his lab’s expertise in environmental toxicants and endocrine disrupters to bear on the new center’s mission of improving society’s understanding of environmental influences on human health.

“In particular, we will contribute our knowledge of those environmental factors such as BPA that influence the nuclear hormone receptors, an area of significant current public health concern,” Gustafsson said.

Center members are focused on translating research advances in environmental causes of disease to improve detection, prevention and management of diseases induced or worsened by environmental exposures.

“We are delighted to welcome the CTEHR team into the Environmental Health Sciences Core Center fold. Under the leadership of Dr. Walker, and with its discovery pipeline and state-of-the-art resources, we expect the center will build teams to address complex questions in health and of concern to communities both locally and nationally,” said Les Reinlib, director for the Environmental Health Sciences Core Centers Program at the National Institute of Environmental Health Sciences, a branch of the NIH. “We are confident that the new center will enhance research and outreach on the interaction of genes with common exposures that may alter our risk for disease.”

Through a novel bench-to-bedside-to-community approach, the center will accelerate the process of advancing basic scientific discoveries and translating them into treatment and prevention approaches for individuals at highest risk for environmental diseases, including vulnerable populations such as children and low socio-economic individuals.

“Understanding and mitigating environmental causes of diseases, such as asthma, heart disease, obesity and cancer, offers the greatest opportunity to decrease disease burden,” Walker said. “Unlike genetic causes of disease, environmental exposures are modifiable, and if detected early, present opportunities for intervention to prevent disease occurrence, and transmission to the next generation.”

CTEHR brings together environmental health scientists from a wide array of fields including cell and molecular biology, structural biology, biochemistry, genetics, pharmacology, physiology, toxicology, epidemiology, veterinary medicine, biostatistics and engineering. Working toward a common goal, the scientists will look at a number of environmental risk factors including: air quality, chemicals, radiation, bacteria and lifestyle choices, such as diet and exercise, to determine the link to disease in humans throughout the course of their lives.

“This is a great opportunity for major Texas institutions to address the environmental health issues of Texas,” said Melissa Bondy, professor in the National Cancer Institute-designated Dan L. Duncan Cancer Center at Baylor College of Medicine and associate director of the new center. “As one of the top 25 medical schools in the country and based in Houston with access to populations with health disparities, Baylor College of Medicine is uniquely positioned to translate environmental health research advances to the clinic and into the community.”

This translational effort will create bridges between center members, surrounding communities and other stakeholders to further scientific collaborations and dissemination of research results. Through fostered resources and expertise, the center will enable individuals, communities and policy makers to make informed decisions about environmental exposures and to mitigate environmental disease risks.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Researchers Develop Advanced Cell Screening Technology for Cancer Immunotherapy
UH-led work could extend the breakthrough therapy to more cancer patients.
Thursday, August 13, 2015
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos